| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 10/07/2010 | US20100254945 Rnai Therapeutic for Respiratory Virus Infection |
| 10/07/2010 | US20100251601 Enhanced production of fatty acid derivatives |
| 10/07/2010 | DE102009013748A1 Bestimmung von Interaktionen konstanter Antikörperteile mit Fc-gamma Rezeptoren Determination of interactions constant antibody portions with Fc-gamma receptors |
| 10/07/2010 | CA2794923A1 Highly acidic chitosan-nucleic acid polyplex compositions |
| 10/07/2010 | CA2757614A1 Chimeras between gpc-receptors and binding partners thereof |
| 10/07/2010 | CA2757493A1 Nucleic acid preparation compositions and methods |
| 10/07/2010 | CA2757333A1 Mouse models |
| 10/07/2010 | CA2757210A1 C6orf167 peptides and vaccines containing the same |
| 10/07/2010 | CA2757178A1 Mutants of activation-induced cytidine deaminase (aid) and methods of use |
| 10/07/2010 | CA2757095A1 Bmp-alk3 antagonists and uses for promoting bone growth |
| 10/07/2010 | CA2757030A1 Newcastle disease virus vectored avian vaccines |
| 10/07/2010 | CA2756988A1 Anti-fcrh5 antibodies and immunoconjugates and methods of use |
| 10/07/2010 | CA2756889A1 Monoclonal antibody capable of binding to specific discontinuous epitope occurring in ad1 region of human cytomegalovirus gb glycoprotein, and antigen-binding fragment thereof |
| 10/07/2010 | CA2756705A1 Engineering the pathway for succinate production |
| 10/07/2010 | CA2755985A1 Genotoxicity testing |
| 10/07/2010 | CA2755310A1 Coryneform bacterium transformant and process for producing isobutanol using the same |
| 10/07/2010 | CA2755027A1 Use of a seed specific promoter to drive odp1 expression in cruciferous oilseed plants to increase oil content while maintaining normal germination |
| 10/07/2010 | CA2749512A1 Antigenic determinants recognized by anti-human death receptor dr5 monoclonal antibody ad5-10, derivatives and use thereof |
| 10/07/2010 | CA2729621A1 Use of id4 for diagnosis and treatment of cancer |
| 10/06/2010 | EP2237030A1 Method for specifically detecting test substance using photocurrent, sensor unit used therefor, and measuring device |
| 10/06/2010 | EP2236629A1 Nucleic acid probe-based diagnostic assays for prokaryotic and eukaryotic organisms |
| 10/06/2010 | EP2236624A1 Method for identifying the genotype and subtype of hepatitis c virus on a biological microchip |
| 10/06/2010 | EP2236622A2 Method for generating circularised nucleic acid |
| 10/06/2010 | EP2236621A1 Methods and sequences for detection and identification of methicillin-resistant Staphylococcus aureus |
| 10/06/2010 | EP2236612A1 Oligonucleotide library encoding randomised peptides |
| 10/06/2010 | EP2236611A1 Lipolytic enzyme variant |
| 10/06/2010 | EP2236610A2 Improved promoter, and a production method for l-lysine using the same |
| 10/06/2010 | EP2236609A2 DNA-based aptamers for human cathepsin G |
| 10/06/2010 | EP2236608A2 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| 10/06/2010 | EP2236607A1 Use of inhibitors of St3Gla6 activity for modulation of adipogenesis |
| 10/06/2010 | EP2236606A2 Ligational encoding of small molecules |
| 10/06/2010 | EP2236605A1 Human anti- 9 integrin antibody |
| 10/06/2010 | EP2236604A1 Anti-nr10 antibody and use thereof |
| 10/06/2010 | EP2236602A1 Lipolytic enzyme variants |
| 10/06/2010 | EP2236601A1 Phytases |
| 10/06/2010 | EP2236600A1 Enzymes |
| 10/06/2010 | EP2236519A1 Human GM-CSF antigen binding proteins |
| 10/06/2010 | EP2236515A1 Component protein pa1698 for type-iii secretion system of pseudomonas aeruginosa |
| 10/06/2010 | EP2236152A1 Albumin fusion proteins |
| 10/06/2010 | EP2236141A1 siDNA oligonucleotide as antiviral agent against Herpes virus Infections |
| 10/06/2010 | EP2235533A2 Screening |
| 10/06/2010 | EP2235198A2 Yeast strains for protein production |
| 10/06/2010 | EP2235189A1 Methods for inhibiting angiogenesis using egfl8 antagonists |
| 10/06/2010 | EP2235188A2 Transgenic non-human animals expressing human blood clotting factors |
| 10/06/2010 | EP2235187A1 An improved mutagenesis method using polyethylene glycol mediated introduction of mutagenic nucleobases into plant protoplasts |
| 10/06/2010 | EP2235186A2 Novel bacillus thuringiensis gene with coleopteran activity |
| 10/06/2010 | EP2235185A1 Woody plants having improved growth charateristics and method for making the same using transcription factors |
| 10/06/2010 | EP2235184A2 Lipid metabolism proteins, combinations of lipid metabolism proteins and uses thereof |
| 10/06/2010 | EP2235183A2 Plants having enhanced yield-related traits and a method for making the same |
| 10/06/2010 | EP2235182A2 Compositions and methods for the suppression of target polynucleotides from lepidoptera |
| 10/06/2010 | EP2235181A1 Display vectors and methods and uses thereof |
| 10/06/2010 | EP2235180A2 Apoptosis inducing positive control for expression modulating experiments |
| 10/06/2010 | EP2235179A2 Methods for creating and identifying functional rna interference elements |
| 10/06/2010 | EP2235178A2 Compositions and methods for modulating vascular endothelial growth factor c (vegf-c) expression |
| 10/06/2010 | EP2235176A1 Enhanced protein production in bacillus |
| 10/06/2010 | EP2235175A1 Polypeptide-nucleic acid conjugates and uses thereof |
| 10/06/2010 | EP2235174A1 Thermophilic and thermoacidophilic biopolymer- degrading genes and enzymes from alicyclobacillus acidocaldarius and related organisms, methods |
| 10/06/2010 | EP2235173A2 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 10/06/2010 | EP2235170A1 Lipid metabolism protein and uses thereof iii (pyruvate-orthophosphate-dikinase) |
| 10/06/2010 | EP2235163A1 Recombinant bcg tuberculosis vaccine for eliciting immune responses to mycobacterium tuberculosis |
| 10/06/2010 | EP2235057A2 G immunoglobulin used against anthrax toxins |
| 10/06/2010 | EP2235051A2 Glycosyltransferases, polynucleotides encoding these and methods of use |
| 10/06/2010 | EP2235050A1 Bs3 resistance gene and methods of use |
| 10/06/2010 | EP2235048A1 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 10/06/2010 | EP2235047A1 Novel bacillus thuringiensis gene with coleopteran activity |
| 10/06/2010 | EP2235034A2 Immunomodulatory agents and methods of use |
| 10/06/2010 | EP2235033A2 Methods and compositions for increasing gene expression |
| 10/06/2010 | EP1969146B1 Methods for nucleic acid mapping and identification of fine-structural-variations in nucleic acids and utilities |
| 10/06/2010 | EP1929012B1 Method for in vitro recombination |
| 10/06/2010 | EP1802753B1 Method for storing dna by using chitosan, and products using the methods |
| 10/06/2010 | EP1784492B1 Multiple rna polymerase iii promoter expression constructs |
| 10/06/2010 | EP1745295B1 Methods, compositions and compound assays for inhibiting amyloid-beta protein production |
| 10/06/2010 | EP1736484B1 An gene engineering recombinant anti-cea, anti-cd3 and anti-cd28 single-chain tri-specific antibody |
| 10/06/2010 | EP1513554B1 Cd16a binding proteins and use for the treatment of immune disorders |
| 10/06/2010 | EP1456650B1 Gfats as modifiers of the p53 pathway and methods of use |
| 10/06/2010 | EP1352077B1 Materials and methods relating to protein aggregation in neurodegenerative disease |
| 10/06/2010 | EP1254369B1 Cells for drug discovery |
| 10/06/2010 | EP1220906B1 Polynucleotides encoding members of the human b lymphocyte activation antigen b7 family and polypeptides encoded thereby |
| 10/06/2010 | EP1131457B1 Systemic viral/ligand gene delivery system and gene therapy |
| 10/06/2010 | EP1100880B1 Urate oxidase |
| 10/06/2010 | EP0873363B1 High affinity human antibodies to tumor antigens |
| 10/06/2010 | CN1970741B Super engineering bacteria, expressed detoxification enzyme thereof, and construction method and application therefor |
| 10/06/2010 | CN1922306B Systems and methods for clonal expression in plants |
| 10/06/2010 | CN1840660B Method of determining dihydropyrimidine dehydrogenase gene expression |
| 10/06/2010 | CN1836049B Methods for detecting aneuploidy using microparticle multiplex detection |
| 10/06/2010 | CN1795267B Stress-induced promoter and method of using the same |
| 10/06/2010 | CN1646684B Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus |
| 10/06/2010 | CN1616665B Targeted liposome gene delivery |
| 10/06/2010 | CN1535318B Quadruplex DNA and duplex probe systems |
| 10/06/2010 | CN101855539A Method and kit for measurement of endotoxin level |
| 10/06/2010 | CN101855356A Two step cluster deletion and humanisation |
| 10/06/2010 | CN101855355A Plants having increased yield-related traits and a method for making the same |
| 10/06/2010 | CN101855354A Plants which synthesize increased amounts of glucosaminglycans |
| 10/06/2010 | CN101855353A Methods of controlling plant seed and organ size |
| 10/06/2010 | CN101855352A Mammary gland-specific human erythropoietin expression vector, transgenic animal and method for producing human erythropoietin using same |
| 10/06/2010 | CN101855351A Compositions and methods for the identification of inhibitors of retroviral infection |
| 10/06/2010 | CN101855350A Method of nuclear reprogramming |
| 10/06/2010 | CN101855349A West nile virus vaccine, and method for production thereof |
| 10/06/2010 | CN101855348A Gene associated with liver cancer, and method for determination of the risk of acquiring liver cancer |
| 10/06/2010 | CN101855347A Novel ATP:citrate lyase genes |